In collaboration with Cytospire Therapeutics, we are evaluating the efficacy of next-generation multispecific antibodies using advanced human immunology and single-cell profiling approaches. Our expertise enables detailed characterization of immune responses, with a particular focus on γδ T cells and other innate and adaptive immune populations. These studies aim to provide mechanistic insights into the activity of Cytospire's immune cell engagers and support the development of innovative cancer immunotherapies.